INDGN logo

Indegene Stock Price

Symbol: NSEI:INDGNMarket Cap: ₹136.4bCategory: Pharmaceuticals & Biotech

INDGN Share Price Performance

₹568.45
4.65 (0.82%)
11.8% undervalued intrinsic discount
₹644.67
Fair Value
₹568.45
4.65 (0.82%)
11.8% undervalued intrinsic discount
₹644.67
Fair Value
Price ₹568.45
AnalystConsensusTarget ₹644.67

INDGN Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget·Updated
Fair Value ₹644.67 11.8% undervalued intrinsic discount

M&A And Cortex Integration Will Expand Enterprise Opportunities

0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative

Recent INDGN News & Updates

No updates

Indegene Limited Key Details

₹29.2b

Revenue

₹624.0m

Cost of Revenue

₹28.6b

Gross Profit

₹24.3b

Other Expenses

₹4.4b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
18.14
Gross Margin
97.87%
Net Profit Margin
14.89%
Debt/Equity Ratio
3.9%

Indegene Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About INDGN

Founded
1998
Employees
4158
CEO
Manish Gupta
WebsiteView website
www.indegene.com

Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technology platforms. Further, it provides analytics, technology, commercial, medical, regulatory, and safety services to life science and healthcare organizations. Indegene Limited was incorporated in 1998 and is based in Bengaluru, India.

Indian Market Performance

  • 7 Days: -0.8%
  • 3 Months: 4.5%
  • 1 Year: -2.1%
  • Year to Date: -1.3%
The market has been flat in the last week, however the Healthcare sector is down 3.5%. In line with that, the market has also been flat over the past year. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading